This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Under $10 Soaring Higher


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Dendreon (DNDN) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients. This stock is trading up 8.1% to $7.69 in recent trading.

Today's Range: $7.25-$7.88

52-Week Range: $5.69-$42.00

Volume: 12.5 million

Three-Month Average Volume: 6.4 million

Shares of DNDN are ripping higher today after Research firm Summer Street initiated coverage on the stock with a buy rating and a price target of $18, citing the potential promise for the their drug Provenge.

>>Stocks With Analyst Upgrades

From a technical perspective, DNDN is showing a continuation momentum pattern today after the stock ripped higher Wednesday with monster volume. This move today is quickly pushing the stock within range of a near-term breakout trade. That trade will hit once DNDN takes out some near-term overhead resistance at $7.88 to $8.10 with high volume.

Traders should now look for long-biased trades if DNDN can sustain a move or close above $7.88 to $8.10 with volume that's near or above 6,360,590 shares. At last check, DNDN has hit an intraday high of $7.88 and volume has already hit over 12 million shares traded. If we get that breakout soon, then look for DNDN to easily tag its 50-day moving average of $8.82, and possibly continue upwards towards $9.30.
3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
DNDN $0.06 -6.02%
GTIV $19.19 -1.18%
XNPT $4.21 -1.86%
AAPL $94.19 -1.04%
FB $118.06 0.54%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs